Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

BENZELMIN EQUINE ANTHELMINTIC ORAL SUSPENSION DIN 02231772

Status: Cancelled Post Market
Holder: AYERST VETERINARY LABORATORIES
Molecule: OXFENDAZOLE

Health Canada record

Active ingredient(s)OXFENDAZOLE 9.06 %
Dosage formSuspension
RouteOral
ScheduleNON-PRESCRIPTION DRUGS
ClassVeterinary
ATC
Original market date21-Sep-1998
Current status date23-Aug-2006
SourceHealth Canada DPD

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing OXFENDAZOLE

DINProductCompanyFormStrengthStatus
00592307BENZELMIN EQUINE ANTHELMINTIC ORAL PASTE 37.5%AYERST VETERINARY LABORATORIESPasteOXFENDAZOLE 37.5 %Cancelled Post Market
00598895BENZELMIN SUSPENSION 90.6MG/MLSYNTEX ANIMAL HEALTH, DIVISION OF SYNTEX INC.SuspensionOXFENDAZOLE 90.6 MGCancelled Post Market
01913379SYNANTHIC 22.5% SUSPENSIONAYERST VETERINARY LABORATORIESSuspensionOXFENDAZOLE 22.5 %Cancelled Post Market
02012480SYNANTHIC SUSPENSION 9.06%SYNTEX ANIMAL HEALTH, DIVISION OF SYNTEX INC.SuspensionOXFENDAZOLE 90.6 MGCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
61802001-10-09Supplement to a New Drug Submission (SNDS)ALTERNATE SOURCE OF ACTIVE INGREDIENT
66171997-08-13New Drug Submission (NDS)
Request a quote for BENZELMIN EQUINE ANTHELMINTIC ORAL SUSPENSION

How to read a Canadian DIN record